• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

“I think providers see trans people as unstable patients”: Exploring substance use communication experiences of transgender and gender diverse adults during primary care encounters.

Psychology of Sexual Orientation and Gender Diversity, Vol 12(3), Sep 2025, 392-401; doi:10.1037/sgd0000692

Numerous studies have linked minority stress to substance use among transgender and genderdiverse (TGD) individuals. Yet, there has been limited research on how TGD patients experience alcohol, tobacco, and other substance use communication with their providers. Therefore, we used qualitative interviews to explore the substance use communication experiences of TGD adults with their primary care providers. We interviewed 25 TGD adults from New England in January and February of 2022. Approximately half (n = 12) of the participants were health care providers themselves, and 14 were nonbinary, genderqueer, genderfluid, or similar identity. Using a thematic analytic approach, we identified three broad themes of TGD adults’ perceptions of substance use communication with their primary care providers: (1) facing stereotypes about TGD people and substance use, (2) encountering a gender essentialist approach to substance use risk screening, (3) perceiving that TGD patients who disclose substance use will appear unstable and may not receive gender-affirming care. Participants raised implications for policy and clinical practice including understanding links between minority stress and substance use, considering alternatives to sex-based metrics when screening for harmful or hazardous substance use, and establishing clinic policies aimed at protecting access to gender-affirming care. More interventions are needed that address provider awareness and promote TGD patient disclosure for risk and harm reduction purposes while ensuring access to gender-affirming care. (PsycInfo Database Record (c) 2025 APA, all rights reserved)

Read the full article ›

Posted in: Journal Article Abstracts on 11/06/2025 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2025 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice